Our targeted approach

Resolve Therapeutics is a clinical stage biopharmaceutical company pioneering a promising new approach to the treatment of autoimmune diseases such as lupus and Sjögren’s syndrome. This new targeted approach to autoimmune inflammation has the potential to transform patients’ lives. Our team of dedicated doctors and scientists is working at the cutting edge of medicine, striving to bring this medicine to patients without delay. Learn more